Indeed, even if the mutational rate of this gene is quite low in CRC patients (about 7–10%), BRAF plays a critical role in the prognosis and for this reason its role would be relevant in our study [40, 41]. The gene discussed is BRAF; the disease is colorectal carcinoma.